Skip to content
Tuesday, 17 November 2026, Lagos
Health

NAFDAC Issues Alert on Counterfeit Contraceptive Injection in Northern States

By Elias Sanusi
NAFDAC Issues Alert on Counterfeit Contraceptive Injection in Northern States

The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public warning regarding the circulation of counterfeit Noristerat Injection 200mg in Nigeria.

The agency has identified the fake contraceptive product in Niger, Bauchi, and Kano States, with a significant presence at the Coordinated Wholesale Centre in Kano.  

In a statement released on Monday, NAFDAC alerted the public to the dangers of using this counterfeit product, which has been found to be mislabeled and repackaged from Chlorpheniramine and Dexamethasone injection ampoules.

“The counterfeit Noristerat Injection 200mg has been found in Kano, Bauchi, and Niger States. This poses a serious health risk as unsuspecting women may be using a product that offers no contraceptive protection,” the agency stated.  

NAFDAC confirmed that the individual responsible for the illegal repackaging has been apprehended, and efforts are underway to remove the counterfeit product from circulation. “We have successfully tracked and arrested the counterfeiter behind this dangerous act. The agency remains committed to ensuring that only genuine and safe medical products are available to the public,” NAFDAC assured.

To help consumers identify and avoid the counterfeit product, NAFDAC provided the following details:

The fake Noristerat Injection bears the registration number 04-5715.
Manufacturing date: September 2022.
Expiry date: September 2027.
Lot Number: KT02TTK.
Genuine Noristerat 200mg is a contraceptive injection designed to provide eight weeks of pregnancy protection for short-term birth control. The counterfeit version circulating poses a risk of unintended pregnancies and other health complications.  

NAFDAC urged the public to exercise vigilance and report any suspicious products to the agency. “We call on healthcare providers, pharmacists, and the general public to report any suspicious Noristerat Injection to NAFDAC. Your cooperation is vital in protecting public health,” the statement emphasized.

The agency reiterated its commitment to protecting public health and assured that enhanced surveillance measures will be implemented to prevent future incidents.

Related stories

Experts Warn: Sugary Drinks Raise Risk of Heart Disease in Children

Health experts have cautioned that regular consumption of sugary beverages can significantly increase the risk of heart disease in children, highlighting growing concerns over childhood nutrition and lifestyle habits. Studies indicate that drinks high in added sugar contribute to obesity, elevated…

NAFDAC Clears Nestlé Infant Formula Sold in Nigeria Amid UK Recall

The National Agency for Food and Drug Administration and Control has assured Nigerians that Nestlé infant formula products available in the country are safe and not affected by the recent product recall announced in the United Kingdom. The clarification follows concerns raised by consumers after…

Health Workers Insist Strike Action Will Continue Amid Unresolved Demands

Health workers across the country have declared their intention to sustain the ongoing strike, citing the failure of authorities to adequately address their outstanding demands. Union leaders said the decision followed consultations with members, who resolved that industrial action would remain in…

Doctors Call for Enhanced Welfare to Stem Brain Drain

Medical professionals across Nigeria are urging the government to improve their welfare and working conditions as a strategy to curb the ongoing “japa” trend, where skilled doctors leave the country in search of better opportunities abroad. They highlighted that poor remuneration, inadequate…